Dr. David R. Close, MD
Medical Oncology (Medical Oncology Physician)
4101 22nd Place
Lubbock, TX 79410
Who else practices at this address →
Lubbock County includes primary care (7% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Medical school
- University of Colorado School of Medicine, Denver (1972)
- Years since graduation
- 54
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 521
Licensed in Texas since 1980, according to the Texas Medical Board. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1972Medical school: University of Colorado School of Medicine, Denver
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Medical Oncology Physician primary
TX license F7723 (first issued 1980; active)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- University Medical Center Lubbock, TX
- Covenant Medical Center Lubbock, TX
- Covenant Childrens Hospital Lubbock, TX
- Grace Surgical Hospital Lubbock, TX
- Covenant Hospital Plainview Plainview, TX
Medical groups
- Covenant Medical Group (233 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 521
- Services billed
- 1,335
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 773 | 324 |
| Established patient office or other outpatient visit, 20-29 minutes | 274 | 233 |
| Established patient office or other outpatient visit, 40-54 minutes | 93 | 73 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 55 | 35 |
| New patient office or other outpatient visit, 45-59 minutes | 49 | 49 |
| Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 37 | 35 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 29 | 20 |
| New patient office or other outpatient visit, 30-44 minutes | 25 | 25 |
| New patient office or other outpatient visit, 60-74 minutes | 19 | 19 |
| Telephone medical discussion with physician, 21-30 minutes | 15 | 15 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Letrozole Other prescribers in Lubbock, TX | 219 |
| Anastrozole Other prescribers in Lubbock, TX | 69 |
| Eliquis (apixaban) Other prescribers in Lubbock, TX | 53 |
| Allopurinol Other prescribers in Lubbock, TX | 50 |
| Ibrance (palbociclib) | 48 |
| Potassium Chloride Other prescribers in Lubbock, TX | 43 |
| Hydroxyurea Other prescribers in Lubbock, TX | 39 |
| Ondansetron Hcl Other prescribers in Lubbock, TX | 35 |
| Tramadol Hcl Other prescribers in Lubbock, TX | 35 |
| Tamoxifen Citrate Other prescribers in Lubbock, TX | 34 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 13 companies reported 33 payments worth $785 in total to this clinician.
| AstraZeneca Pharmaceuticals LP | $135 |
|---|---|
| Pfizer Inc. | $80.63 |
| Janssen Biotech, Inc. | $77.66 |
| Jazz Pharmaceuticals Inc. | $66.89 |
| Genentech USA, Inc. | $65.34 |
| Novartis Pharmaceuticals Corporation | $62.73 |
| Array Biopharma Inc | $55.58 |
| Merck Sharp & Dohme LLC | $54.76 |
| Food and Beverage | $785 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.